Arnhold LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.3M | Buy |
971,797
+12,000
| +1% | +$319K | 2% | 10 |
|
|
2025
Q4 | $23.9M | Buy |
959,797
+183,299
| +24% | +$4.62M | 1.81% | 13 |
|
|
2025
Q3 | $19.8M | Buy |
776,498
+4,236
| +0.5% | +$105K | 1.65% | 18 |
|
|
2025
Q2 | $18.7M | Buy |
772,262
+78,780
| +11% | +$1.84M | 1.71% | 17 |
|
|
2025
Q1 | $17.6M | Sell |
693,482
-65,264
| -9% | -$1.71M | 1.78% | 21 |
|
|
2024
Q4 | $20.1M | Buy |
758,746
+106,267
| +16% | +$2.88M | 1.98% | 17 |
|
|
2024
Q3 | $18.9M | Buy |
652,479
+3,755
| +0.6% | +$110K | 1.83% | 20 |
|
|
2024
Q2 | $18.2M | Sell |
648,724
-62,124
| -9% | -$1.71M | 1.92% | 17 |
|
|
2024
Q1 | $19.7M | Buy |
710,848
+140,829
| +25% | +$3.91M | 2.09% | 16 |
|
|
2023
Q4 | $16.4M | Buy |
570,019
+10,161
| +2% | +$307K | 1.83% | 17 |
|
|
2023
Q3 | $18.6M | Buy |
559,858
+204,670
| +58% | +$7.24M | 2.21% | 9 |
|
|
2023
Q2 | $13M | Buy |
355,188
+33,733
| +10% | +$1.31M | 1.48% | 24 |
|
|
2023
Q1 | $13.1M | Buy |
321,455
+93,088
| +41% | +$4.02M | 1.49% | 23 |
|
|
2022
Q4 | $11.7M | Sell |
228,367
-16,500
| -7% | -$791K | 1.43% | 25 |
|
|
2022
Q3 | $10.7M | Hold |
244,867
| – | – | 1.44% | 22 |
|
|
2022
Q2 | $12.8M | Sell |
244,867
-4,709
| -2% | -$240K | 1.53% | 22 |
|
|
2022
Q1 | $12.9M | Buy |
249,576
+88,485
| +55% | +$4.59M | 1.45% | 25 |
|
|
2021
Q4 | $9.51M | Sell |
161,091
-119,094
| -43% | -$5.9M | 1.08% | 35 |
|
|
2021
Q3 | $12.1M | Sell |
280,185
-157,082
| -36% | -$6.96M | 1.39% | 29 |
|
|
2021
Q2 | $17.1M | Sell |
437,267
-66,788
| -13% | -$2.6M | 1.94% | 14 |
|
|
2021
Q1 | $18.3M | Buy |
504,055
+259,435
| +106% | +$9.21M | 2.19% | 12 |
|
|
2020
Q4 | $9M | Sell |
244,620
-80,296
| -25% | -$2.95M | 1.17% | 29 |
|
|
2020
Q3 | $11.3M | Sell |
324,916
-131,081
| -29% | -$4.6M | 1.67% | 16 |
|
|
2020
Q2 | $14.1M | Buy |
455,997
+113,204
| +33% | +$3.85M | 2.25% | 9 |
|
|
2020
Q1 | $10.6M | Buy |
342,793
+241,545
| +239% | +$8.23M | 1.96% | 13 |
|
|
2019
Q4 | $3.76M | Hold |
101,248
| – | – | 0.59% | 46 |
|
|
2019
Q3 | $3.45M | Hold |
101,248
| – | – | 0.59% | 45 |
|
|
2019
Q2 | $4.16M | Sell |
101,248
-5,270
| -5% | -$209K | 0.73% | 42 |
|
|
2019
Q1 | $4.29M | Hold |
106,518
| – | – | 0.77% | 40 |
|
|
2018
Q4 | $4.41M | Hold |
106,518
| – | – | 0.82% | 39 |
|
|
2018
Q3 | $4.45M | Sell |
106,518
-142,817
| -57% | -$5.5M | 0.77% | 40 |
|
|
2018
Q2 | $8.58M | Buy |
249,335
+23,820
| +11% | +$814K | 1.51% | 21 |
|
|
2018
Q1 | $7.59M | Buy |
+225,515
| New | +$7.75M | 1.43% | 17 |
|
Other funds holding PFE
VCM
VPM
Arnhold LLC's PFE Position: Q1 2026 in Review
Arnhold LLC increased its Pfizer (PFE) stake by 1.3% in Q1 2026, buying an estimated $319K and bringing the position to 971,797 shares worth $27.3M. The position accounts for 2% of the portfolio, ranked #10.
Arnhold LLC first reported a position in PFE in Q1 2018 and has held it in 33 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Arnhold LLC held 971,797 shares of Pfizer worth $27.3M as of Q1 2026.
- Arnhold LLC bought 12,000 Pfizer shares in Q1 2026, an estimated $319K.
- Pfizer made up 2% of Arnhold LLC's portfolio in Q1 2026, its #10 holding.
- Arnhold LLC first reported a position in Pfizer in Q1 2018 and has held it in 33 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Arnhold LLC's 13F filing for Q1 2026, filed 11 May 2026.